Business Of Biotech

221 Folgen

1. IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel

   Vom: 18.12.2023
2. Public Sector Forged, Private Sector Tested with Renovaro BioSciences' Mark Dybul, M.D.

   Vom: 11.12.2023
3. mRNA Vaccine Platforms with Combined Therapeutics' Dr. Romain Micol

   Vom: 4.12.2023
4. Biotech Dealmaking with Regeneron's Nouhad Husseini

   Vom: 27.11.2023
5. Backpacks And Biotech with Luke Timmerman

   Vom: 20.11.2023
6. RNA Delivery Business with Liberate's Shawn Davis, Ph.D. & Walter Strapps, Ph.D.

   Vom: 13.11.2023
7. The Legendary Steve Gorlin's Golden Rules

   Vom: 6.11.2023
8. UPCOMING SPECIAL: Unraveling Biotech's Legal Enigmas With Keir LoIacono

   Vom: 1.11.2023
9. CDMO + Emerging Bio Partnership with Forge's John Maslowski and Ray's Jenny Holt

   Vom: 30.10.2023
10. Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.

    Vom: 23.10.2023
11. Bio Career Moves with Codagenix's Johanna Kaufmann, Ph.D.

    Vom: 16.10.2023
12. Veteran Advice From The C-Suite with Citius' Leonard Mazur

    Vom: 9.10.2023
13. Don't Be A D**k with Ochre Bio's Quin Wills, M.D., Ph.D.

    Vom: 2.10.2023
14. Pragmatic Computational Biology with Andrew Satz

    Vom: 25.9.2023
15. Commercial Readiness with Orca Bio's Dan Kirby

    Vom: 18.9.2023
16. Bio & The Business Of Aging with Life Biosciences' Jerry McLaughlin

    Vom: 11.9.2023
17. Fiscal Turnarounds with Protalix's Eyal Rubin

    Vom: 4.9.2023
18. Building LEO Pharma's U.S. Presence with Brian Hilberdink

    Vom: 28.8.2023
19. Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD

    Vom: 21.8.2023
20. Facing NASH Therapeutic Skepticism with 89bio's Rohan Palekar

    Vom: 14.8.2023